Investment Research & Advisory Group’s AbbVie ABBV Stock Holding History

Investment Research & Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Buy	896 +5	+0.6%	+$1.08K	0.07%	78
2026 Q1	$203K	Buy	891 +3	+0.3%	+$665	0.07%	75
2025 Q4	$211K	Buy	888 +4	+0.5%	+$911	0.07%	74
2025 Q3	$213K	Buy	884 +5	+0.6%	+$1.02K	0.07%	73
2025 Q2	$163K	Sell	879 -434	-33%	-$80.7K	0.06%	75
2025 Q1	$275K	Buy	1,313 +120	+10%	+$23.3K	0.11%	58
2024 Q4	$212K	Hold	1,193	–	–	0.09%	65
2024 Q3	$236K	Hold	1,193	–	–	0.1%	62
2024 Q2	$205K	Hold	1,193	–	–	0.09%	64
2024 Q1	$217K	Hold	1,193	–	–	0.1%	61
2023 Q4	$185K	Hold	1,193	–	–	0.09%	66
2023 Q3	$178K	Hold	1,193	–	–	0.1%	64
2023 Q2	$161K	Hold	1,193	–	–	0.09%	68
2023 Q1	$190K	Hold	1,193	–	–	0.12%	63
2022 Q4	$193K	Hold	1,193	–	–	0.13%	63
2022 Q3	$160K	Hold	1,193	–	–	0.12%	62
2022 Q2	$183K	Hold	1,193	–	–	0.13%	60
2022 Q1	$193K	Hold	1,193	–	–	0.12%	63
2021 Q4	$162K	Hold	1,193	–	–	0.1%	65
2021 Q3	$129K	Hold	1,193	–	–	0.08%	70
2021 Q2	$134K	Hold	1,193	–	–	0.09%	75
2021 Q1	$129K	Hold	1,193	–	–	0.09%	68
2020 Q4	$128K	Hold	1,193	–	–	0.1%	71
2020 Q3	$104K	Hold	1,193	–	–	0.09%	70
2020 Q2	$117K	Hold	1,193	–	–	0.11%	65
2020 Q1	$91K	Buy	1,193 +500	+72%	+$42.6K	0.08%	64
2019 Q4	$61K	Buy	+693	New	+$57.5K	0.06%	99

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Investment Research & Advisory Group's ABBV Position: Q2 2026 in Review

Investment Research & Advisory Group increased its AbbVie (ABBV) stake by 0.56% in Q2 2026, buying an estimated $1.08K and bringing the position to 896 shares worth $235K. The position accounts for 0.07% of the portfolio, ranked #78.

Investment Research & Advisory Group first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $275K in Q1 2025. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Investment Research & Advisory Group held 896 shares of AbbVie worth $235K as of Q2 2026.
Investment Research & Advisory Group bought 5 AbbVie shares in Q2 2026, an estimated $1.08K.
AbbVie made up 0.07% of Investment Research & Advisory Group's portfolio in Q2 2026, its #78 holding.
Investment Research & Advisory Group first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
Investment Research & Advisory Group's AbbVie position peaked at $275K in Q1 2025.
1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Investment Research & Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.